DEFINITIVE PROXY STATEMENT

Company

Protalix BioTherapeutics, Inc.

Filed

October 3, 2008

Period of Report

November 9, 2008

Accession Number

0000950123-08-012018

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →